How to Build a Raw Material Specification Sheet for Herbal Supplement Ingredients

A raw material specification sheet that reads “appears as described by supplier” isn’t a specification — it’s a liability. FDA investigators have cited that exact language in Form 483 observations, and supplement brands have paid for it with warning letters, import alerts, and product recalls that wiped out hundreds of thousands of dollars in inventory before the root cause was even traced.

Under 21 CFR Part 111 — the GMP regulation for dietary supplements — manufacturers must establish written specifications for every component that goes into a finished product. Botanical raw materials, excipients, and processing aids alike. The regulation has been enforceable since 2010, yet component specification failures still appear in roughly 38% of supplement-related warning letters. Most of those failures trace back to spec sheets that were incomplete, unverifiable, or written to match a supplier’s CoA rather than independently protect the brand.

Here’s how to build one that actually holds up.

What 21 CFR Part 111 Actually Requires

The GMP rule doesn’t tell you what your specifications must say — it tells you what they must cover. Specifically, § 111.70(b) requires you to establish specifications for the identity, purity, strength, and composition of each dietary ingredient component. You must also establish limits on any contamination — chemical, microbiological, or physical — that could cause the finished product to be adulterated or unsafe.

That last part is where most Midwest supplement brands fall short. Identity gets some attention. Purity occasionally shows up. Contamination limits — particularly microbial counts and elemental impurities — frequently get left to the supplier’s CoA, which is exactly what FDA’s guidance says is insufficient. The regulation requires you to verify incoming components against your own specifications, using qualified analytical laboratories. A supplier’s CoA can support your testing data; it cannot replace it.

The American Herbal Products Association (AHPA) publishes voluntary guidance on raw material specification development that aligns closely with FDA expectations and is worth using as a benchmarking framework. But the regulatory floor is 21 CFR Part 111, and many spec sheets don’t even reach it.

The Six Components Every Herbal Raw Material Spec Sheet Needs

Step 1: Botanical Identity Parameters

Start with the genus, species, and plant part — not just the common name. “Elderberry extract” is not a specification. “Sambucus nigra L., dried fruit extract, 5:1 concentration ratio, spray-dried” is the beginning of one. Include documented country of origin where your supplier has it, since geographic provenance affects active compound ranges and contamination risk profiles.

For the identity verification method, your spec should explicitly call out the accepted analytical technique: HPTLC (high-performance thin-layer chromatography), DNA barcoding (ITS2 or rbcL sequencing), or both. Analytical laboratories running dual-method identity testing on commercially sourced botanicals like ashwagandha, turmeric, and valerian routinely detect substitution or adulteration in 15–25% of lots. The method you specify determines whether your receiving test can catch that before it enters your blending suite.

Step 2: Physical and Chemical Parameters

Include appearance (color, form, odor), mesh or particle size (80 mesh or finer for most dried botanical powders), moisture content (≤ 10% w/w is the typical upper limit for dried root and leaf powders, though some materials run tighter), total ash, and bulk/tap density if relevant to your fill-weight tolerances.

These parameters catch straightforward quality degradation — clumping, oxidation, caking, moisture uptake — before it reaches manufacturing. They’re also the fastest to verify on receipt, which gives your quality team a workable first gate that doesn’t require a full analytical run on every lot.

Step 3: Active Marker Compound Ranges

For standardized botanical extracts, specify the marker compound and set both a lower and upper acceptance limit. A spec that says “minimum 5% withanolides” is incomplete. “Withanolides: 5.0%–8.0% (w/w) by HPLC per USP <561> or equivalent validated method” is defensible. The upper limit matters because over-potent raw material can throw off label claim calculations just as badly as under-potent material.

Don’t copy the supplier’s claimed value and use it as your specification. Validate the number. Accredited analytical laboratories with reversed-phase HPLC and UV/Vis capability can run marker quantification against USP reference standards — that data becomes the documented basis for your in-house specification, not the supplier’s marketing sheet.

Step 4: Microbiological Limits per USP <61> and <62>

USP Chapter <61> defines methods for total aerobic microbial count (TAMC) and total yeast and mold count (TYMC). USP <62> covers specified microorganisms — the pathogens that require confirmed absence. For herbal botanical powders intended for oral use, the standard acceptance criteria are:

• TAMC: ≤ 10⁵ CFU/g
• TYMC: ≤ 10³ CFU/g
• Escherichia coli: absent in 1 g (tested)
• Salmonella spp.: absent in 10 g (tested)

Your spec sheet should state these limits explicitly, with the USP chapter number and test method referenced. “Meets supplier microbiological specs” is not a limit — it’s a delegation of responsibility that your FDA investigator will not accept and that you cannot defend in litigation.

Step 5: Elemental Impurity Limits per USP <232> and <233>

USP <232> establishes permitted daily exposure (PDE) limits for elemental impurities; USP <233> defines the ICP-MS procedure used to measure them. For oral-route ingredients, the Class 1 element PDEs are: lead ≤ 5 μg/day, cadmium ≤ 5 μg/day, inorganic arsenic ≤ 15 μg/day, and inorganic mercury ≤ 15 μg/day.

Here’s where Midwest brands distributing nationally need to pay particular attention: California’s Proposition 65 threshold for lead is 0.5 μg/day — the maximum allowable dose level (MADL) for reproductive toxicity — which is 10× more stringent than the USP PDE. Any brand selling product online is effectively selling into California. Your raw material specifications need to reflect that tighter daily exposure calculation if your intended label dose puts customers near the threshold.

Your spec sheet should express elemental limits both as concentration in the raw material (μg/g) and as daily exposure at the intended use level (μg/day). Require ICP-MS data from your supplier with every incoming lot, and verify against your own limits using an ISO 17025-accredited analytical laboratory — not just file the supplier’s number.

Step 6: Retest Date and Storage Conditions

Every herbal raw material has a stability profile. Specify the retest interval (24–36 months is typical for dried botanicals with ≤ 10% moisture and proper storage; shorter for oxidation-sensitive or high-moisture materials) and required storage conditions — temperature range, relative humidity ceiling, light exclusion if the material is photolabile.

When a raw material has been in your facility past its retest date, it cannot be released for use without retesting against identity, purity, and the relevant safety parameters in your spec. State that policy explicitly in the specification document itself, because FDA will ask for documented evidence that expired or out-of-date-hold materials were handled properly.

How Analytical Laboratories Validate Your Specification Numbers

Validation isn’t about receiving a CoA from your supplier and filing it. Under § 111.75, you are required to conduct at least one appropriate test or examination to verify the identity of each dietary ingredient component. For most botanicals, a visual inspection does not meet that standard. You need instrumental analysis.

ISO 17025-accredited analytical laboratories operate under a quality management system that includes method validation records, measurement uncertainty documentation, and regular proficiency testing. That accreditation matters when you’re defending your specification data to an FDA investigator or explaining a product recall to a retailer. It means the data was generated under a controlled, auditable process — not just printed on a supplier’s letterhead.

For botanical identity, HPTLC is the method most consistently referenced in AHPA guidelines and USP botanical monographs. It produces a chromatographic fingerprint that can confirm species identity and detect common adulterants in a single analytical run. DNA barcoding — typically ITS2 or rbcL sequencing — adds a second confirmatory layer and is especially useful for identifying species-level substitution in complex multi-herb blends where HPTLC fingerprints may overlap. For elemental impurities, ICP-MS measures concentrations across the full USP <232> element panel in the parts-per-billion range in a single run.

What you’re building, when you combine a well-written specification with third-party data from a qualified analytical laboratory, is a defensible chain of documentation. Component received → tested against written specification → CoA attached to lot → release or deviation decision recorded. That chain is what demonstrates “reasonable certainty of no harm” under DSHEA and “component identity verified” under 21 CFR Part 111.

The Spec Sheet Gaps That Keep Appearing in FDA Warning Letters

Three failure patterns dominate the public record of supplement-related enforcement:

Vague or circular specifications. Language that defers to the supplier — “meets supplier specifications,” “as labeled,” “per attached certificate of analysis” — fails the 21 CFR Part 111 standard consistently. Your specification must be independent of your supplier’s claims. If you can’t verify it against your own documented limit, it isn’t a specification.

Missing contamination limits. Brands that carefully specify marker compound content but leave microbiological and heavy metal limits blank are addressing identity while ignoring safety. FDA treats contamination limits as a mandatory component of the specification, not an optional detail for high-risk herbs only.

No documented verification testing. Even a well-constructed spec sheet is useless if you can’t prove the incoming lot was actually tested against it. Batch records must connect each component receipt to a test report from a qualified laboratory — ideally one with ISO 17025 accreditation. “We trust this supplier and have for years” is not a GMP record.

---

Build the spec sheet first, then find the analytical data to validate it — not the other way around. Set your limits based on regulatory requirements (USP chapters, 21 CFR Part 111, Prop 65 daily exposure calculations where applicable), verify them against real numbers from accredited analytical laboratories, and document everything in a format your quality team can actually use at the receiving dock.

If your current spec sheets wouldn’t survive a supplier audit or a pre-inspection document request, the gaps are almost certainly in the contamination limits and the documented verification testing — not the identity description at the top of the page.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Related from our network

• ISO 17025 Accredited Botanical Identity and Adulteration Testing — Qalitex Laboratories runs HPTLC and DNA barcoding for species confirmation on incoming herbal raw materials, with CoAs issued under full ISO 17025 accreditation.
• ICP-MS Heavy Metal Testing for Dietary Supplements under USP <232>/<233> — Full elemental impurity panels for herbal ingredients, with Prop 65 exposure calculations included on request.